4.5 Article

Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 66, 期 3, 页码 1193-1211

出版社

IOS PRESS
DOI: 10.3233/JAD-180713

关键词

Alzheimer's disease; amyloid-beta; cognitive decline; episodic memory; polygenic risk scores

资金

  1. Commonwealth Scientific Industrial and research Organization (CSIRO)
  2. Edith Cowan University (ECU)
  3. Mental Health Research institute (MHRI)
  4. National Ageing Research Institute (NARI)
  5. Austin Health
  6. CogState Ltd.
  7. National Health and Medical Research Council (NHMRC)
  8. Dementia Collaborative Research Centres program (DCRC2)
  9. Science and Industry Endowment Fund (SIEF)
  10. Cooperative Research Centre (CRC) for Mental Health, an Australian Government Initiative [20100104]

向作者/读者索取更多资源

Background: With the exception of APOE, genetic variants associated with increased Alzheimer's disease (AD) risk are characterized by small effect sizes. Polygenic risk scores (PRS) have shown utility in predicting AD risk; however, their utility for predicting decline in cognition at preclinical stages of AD is poorly understood. Objective: To validate associations of a 22-variant AD-risk-weighted PRS with AD risk and related biomarkers and to assess its utility to predict cognitive decline. Methods: The PRS was evaluated with respect to brain amyloid-beta (A beta) burden, cerebrospinal fluid (CSF) A beta(42), total-tau, and phospho-tau, and decline in cognition in 643 (570 cognitively normal (CN), 73 AD) PET-imaged participants from the longitudinal Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Ageing. Cognition was assessed using three composite measures; global cognition, verbal episodic memory, and a Pre-Alzheimer's Cognitive Composite (PACC). Results: PRS, both with and without APOE, were positively correlated with brain A beta burden, CSF total-tau, and phosphotau in CN older adults. Further, in CN biomarker positive (A beta(high)) participants, significant associations were observed with baseline and longitudinal cognition. However, this association was not observed after the removal of APOE. Partitioning the PRS into quartiles revealed that the PRS associations with cognitive decline in A beta(high) CN older adults is due to a saturating effect of APOE genotype. Conclusions: An AD-risk-weighted PRS is associated with cognitive decline in CN older adults. However, this association is absent when APOE genotype is excluded from the PRS, suggesting that associations with cognitive decline in this model of polygenic risk are driven by APOE genotype alone. Further research is needed to define appropriate PRSs with greater utility for predicting preclinical AD cognitive decline.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据